These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 16389539)

  • 1. Probiotics to prevent urinary tract infections: the rationale and evidence.
    Reid G; Bruce AW
    World J Urol; 2006 Feb; 24(1):28-32. PubMed ID: 16389539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review.
    Barrons R; Tassone D
    Clin Ther; 2008 Mar; 30(3):453-68. PubMed ID: 18405785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent urinary tract infections in women: How promising is the use of probiotics?
    Gupta V; Nag D; Garg P
    Indian J Med Microbiol; 2017; 35(3):347-354. PubMed ID: 29063878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Lactobacillus spp. to prevent recurrent urinary tract infections in females.
    Ng QX; Peters C; Venkatanarayanan N; Goh YY; Ho CYX; Yeo WS
    Med Hypotheses; 2018 May; 114():49-54. PubMed ID: 29602464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of lactobacillus probiotics in the treatment or prevention of urogenital infections--a systematic review.
    Abad CL; Safdar N
    J Chemother; 2009 Jun; 21(3):243-52. PubMed ID: 19567343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotics and the urologist.
    Bruce AW; Reid G
    Can J Urol; 2003 Apr; 10(2):1785-9. PubMed ID: 12773227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactobacilli for prevention of urogenital infections: a review.
    Marelli G; Papaleo E; Ferrari A
    Eur Rev Med Pharmacol Sci; 2004; 8(2):87-95. PubMed ID: 15267122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies.
    Falagas ME; Betsi GI; Tokas T; Athanasiou S
    Drugs; 2006; 66(9):1253-61. PubMed ID: 16827601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotic agents to protect the urogenital tract against infection.
    Reid G
    Am J Clin Nutr; 2001 Feb; 73(2 Suppl):437S-443S. PubMed ID: 11157354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Prophylactic Oral and/or Vaginal Probiotic Supplementation in the Prevention of Recurrent Urinary Tract Infections: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Gupta V; Mastromarino P; Garg R
    Clin Infect Dis; 2024 May; 78(5):1154-1161. PubMed ID: 38084984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral probiotics can resolve urogenital infections.
    Reid G; Bruce AW; Fraser N; Heinemann C; Owen J; Henning B
    FEMS Immunol Med Microbiol; 2001 Feb; 30(1):49-52. PubMed ID: 11172991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotic Lactobacilli for urogenital health in women.
    Reid G
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S234-6. PubMed ID: 18685506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells.
    Zárate G; Nader-Macias ME
    Lett Appl Microbiol; 2006 Aug; 43(2):174-80. PubMed ID: 16869901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Lactobacillus to prevent infection by pathogenic bacteria.
    Reid G; Burton J
    Microbes Infect; 2002 Mar; 4(3):319-24. PubMed ID: 11909742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotic Therapy and Functional Foods for Prevention of Urinary Tract Infections: State of the Art and Science.
    Reid G
    Curr Infect Dis Rep; 2000 Dec; 2(6):518-522. PubMed ID: 11095902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of lactobacilli and probiotics in maintaining vaginal health.
    Borges S; Silva J; Teixeira P
    Arch Gynecol Obstet; 2014 Mar; 289(3):479-89. PubMed ID: 24170161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urogenital pathogen inhibition and compatibility between vaginal Lactobacillus strains to be considered as probiotic candidates.
    Juárez Tomás MS; Saralegui Duhart CI; De Gregorio PR; Vera Pingitore E; Nader-Macías ME
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):399-406. PubMed ID: 21862199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1 but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA.
    Gardiner GE; Heinemann C; Bruce AW; Beuerman D; Reid G
    Clin Diagn Lab Immunol; 2002 Jan; 9(1):92-6. PubMed ID: 11777835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women.
    Reid G; Charbonneau D; Erb J; Kochanowski B; Beuerman D; Poehner R; Bruce AW
    FEMS Immunol Med Microbiol; 2003 Mar; 35(2):131-4. PubMed ID: 12628548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal colonization by orally administered Lactobacillus rhamnosus GG.
    Colodner R; Edelstein H; Chazan B; Raz R
    Isr Med Assoc J; 2003 Nov; 5(11):767-9. PubMed ID: 14650098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.